Summary & Overview
CPT 52204: Cystourethroscopy with Biopsy
CPT code 52204 is a key billing code in urology, representing cystourethroscopy with biopsy(s), a procedure used to diagnose and evaluate bladder and urethral conditions. This code is widely utilized in outpatient settings, including hospital outpatient departments and ambulatory surgery centers, and is recognized by major national payers such as Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare.
The publication provides a comprehensive overview of 52204, including its clinical context, typical sites of service, and its role in the diagnosis of conditions such as acute cystitis, hematuria, and unspecified bladder disorders. Readers will gain insight into relevant policy updates, coding benchmarks, and the importance of accurate documentation for this procedure. The analysis also highlights common modifiers, associated taxonomies, and related CPT codes, offering a clear understanding of how 52204 fits within broader urology billing and reimbursement practices.
This summary serves as a resource for healthcare professionals, administrators, and policy analysts seeking to stay informed about national trends and requirements for cystourethroscopy with biopsy(s), ensuring clarity in coding and compliance across payer networks.
CPT Code Overview
CPT code 52204 describes cystourethroscopy with biopsy(s), a procedure performed by urologists to visually examine the bladder and urethra using an endoscope and obtain tissue samples for further analysis. This service is classified under urology (endoscopy) and is typically provided in an outpatient setting, such as a hospital outpatient department or ambulatory surgery center (ASC). The procedure is essential for diagnosing and evaluating various bladder and urethral conditions, allowing for targeted tissue sampling during endoscopic examination.
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult presenting to a urology clinic or outpatient hospital setting with symptoms such as hematuria (blood in urine), urinary frequency, or signs of bladder inflammation. The urologist performs a cystourethroscopy to directly visualize the bladder and urethra. During the procedure, suspicious areas are identified and biopsies are taken for further pathological evaluation. This workflow is common for patients with acute cystitis, unexplained hematuria, or other bladder disorders.
Coding Specifications
- Modifier
22: Used when the cystourethroscopy with biopsy requires significantly greater time, effort, or complexity than usual. This may occur in cases with challenging anatomy or extensive disease.
| Provider Taxonomy Code | Specialty Description |
|---|---|
2084U0006X | Urology |
208000000X | Medical and Clinical Laboratory (if biopsy tissue processing, though typically pathology) |
- Urology (
2084U0006X): Physicians specializing in urinary tract procedures, including cystourethroscopy. - Medical and Clinical Laboratory (
208000000X): May be involved if biopsy tissue is processed, though pathology is typically responsible.
Related Diagnoses
-
N30.00: Acute cystitis without hematuria- Relevant for patients presenting with bladder inflammation but no blood in urine, often prompting cystourethroscopy and biopsy to rule out other causes.
-
N30.01: Acute cystitis with hematuria- Indicates bladder inflammation with blood in urine, a common indication for cystourethroscopy and biopsy to assess for malignancy or other pathology.
-
N32.9: Bladder disorder, unspecified- Used when the patient has bladder symptoms or findings that are not clearly defined, warranting further investigation with cystourethroscopy and biopsy.
-
R31.9: Hematuria, unspecified- Represents unexplained blood in urine, a frequent reason for cystourethroscopy and biopsy to identify the underlying cause.
-
R35.0: Frequency of micturition- Applies to patients with increased urinary frequency, which may be associated with bladder pathology requiring cystourethroscopy and biopsy.
Related CPT Codes
-
52214: Cystourethroscopy, with fulguration (including cryosurgery or laser surgery) of trigone, bladder neck, prostatic fossa, urethra, or periurethral glands- This code is used when, in addition to visualization, the provider performs fulguration (destruction) of lesions in specific areas. It may be used as an alternative or in conjunction with
52204if both biopsy and fulguration are performed.
- This code is used when, in addition to visualization, the provider performs fulguration (destruction) of lesions in specific areas. It may be used as an alternative or in conjunction with
-
52224: Cystourethroscopy, with fulguration (including cryosurgery or laser surgery) or treatment of MINOR (less than 0.5 cm) lesion(s) with or without biopsy- This code applies when minor lesions are treated during cystourethroscopy, with or without biopsy. It is often used as an alternative to
52204when the focus is on treating small lesions rather than solely performing biopsies.
- This code applies when minor lesions are treated during cystourethroscopy, with or without biopsy. It is often used as an alternative to
-
These codes may be used together if both biopsy and lesion treatment are performed, or as alternatives depending on the clinical findings during cystourethroscopy.
National Reimbursement Benchmarks
Medicare's national mean rate for CPT code 52204 is $368.61, closely aligned with the BUCA (average commercial) mean rate of $372.71. Among commercial payers, UnitedHealth Group stands out with the highest mean rate at $541.97, while Aetna is the lowest at $261.15.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies significantly across payers. Medicare exhibits the tightest range ($44.00), indicating relatively consistent reimbursement. In contrast, UnitedHealth Group shows the widest range ($277.81), reflecting substantial variability in rates. Cigna and BUCA also display broader ranges, while Aetna and Blue Cross Blue Shield fall in the middle.
The table and chart below present a detailed breakdown of national benchmarks for each payer.
State Benchmarks
State: AK1 / 50
Alaska Benchmarks
Alaska exhibits a notably wide range in reimbursement rates for CPT code 52204, with Aetna showing the largest spread between the 25th and 75th percentiles ($153.50), while UnitedHealth Group demonstrates minimal variation ($8.83). This suggests that some payers, particularly Aetna, have substantial internal rate variability, whereas others, like UnitedHealth Group, maintain more consistent pricing across providers.
Compared to national averages, all commercial payers in Alaska reimburse at significantly higher rates, with Aetna's mean rate nearly four times the national mean. The table and chart below present the full breakdown of payer-specific rates, highlighting the substantial differences in reimbursement across the state.
Key Insights for Alaska
- Aetna is the highest paying payer for CPT 52204 in Alaska, with a mean rate of $984.02, while Medicare is the lowest at $355.65.
- All commercial payers in Alaska reimburse at rates significantly above their respective national averages, with Aetna's mean rate nearly four times the national mean.
- The rate spread is widest for Aetna ($153.50) and narrowest for UnitedHealth Group ($8.83), indicating substantial variation in commercial payer pricing.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.